MedPath
NMPA Approval

Peramivir Injection

国药准字H20244971

September 26, 2024

Drug Information

帕拉米韦注射液

注射剂

60ml∶0.3g(按C₁₅H₂₈N₄O₄计)

化学药品

September 26, 2024

Company Information

Applicant Company

天津西青学府工业区管理委员会办公室108室

Manufacturing Company

天津市西青区精武镇津文公路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath